MORF Morphic Holding, Inc.

Morphic Holding, Inc. operates as a biopharmaceutical company, which engages in the research and development of oral small-molecule integrin therapeutics. It operates a Morphic integrin technology platform, MInT platform, to create a broad pipeline of programs across a variety of therapeutic areas. The company was founded by Timothy A. Springer in August 2014 and is headquartered in Waltham, MA.

$48.78  -0.73 (-1.47%)
As of 05/07/2021 15:59:57 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  06/27/2019
Outstanding shares:  36,214,367
Average volume:  127,172
Market cap:   $1,792,973,310
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    61775R105
ISIN:        US61775R1059
Sedol:      BK8M4J4
Valuation   (See tab for details)
PE ratio:   -35.60
PB ratio:   4.77
PS ratio:   42.07
Return on equity:   -7.66%
Net income %:   -66.35%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy